Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Merck
Mallinckrodt
Moodys
Harvard Business School

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

COUMADIN Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Coumadin, and when can generic versions of Coumadin launch?

Coumadin is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in COUMADIN is warfarin sodium. There are twenty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.

Drug patent expirations by year for COUMADIN
Drug Prices for COUMADIN

See drug prices for COUMADIN

Drug Sales Revenue Trends for COUMADIN

See drug sales revenues for COUMADIN

Recent Clinical Trials for COUMADIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sir Run Run Shaw HospitalPhase 3
Shanghai 5th People's HospitalPhase 3
Yantai Yuhuangding HospitalPhase 3

See all COUMADIN clinical trials

Pharmacology for COUMADIN
Drug ClassVitamin K Antagonist
Mechanism of ActionVitamin K Inhibitors
Synonyms for COUMADIN
(.+/-.)-Warfarin
(Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
(Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine [French]
(R)-(+)-Warfarin
(RS)-Warfarin
006W854
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
2-HYDROXY-3-(3-OXO-1-PHENYL-BUTYL)CHROMEN-4-ONE
2-hydroxy-3-(3-oxo-1-phenylbutyl)-1-benzopyran-4-one
2-hydroxy-3-(3-oxo-1-phenylbutyl)-4h-chromen-4-one
2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one
2-Hydroxy-3-(alpha-(2-oxopropyl)benzyl)-4H-1-benzopyran-4-one
2-oxidanyl-3-(3-oxidanylidene-1-phenyl-butyl)chromen-4-one
200 coumarin
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, & salts, when present at concentrations greater than 0.3%
2H-1-Benzopyran-2-one,4-hydroxy-3-(3-oxo-1-phenylbutyl)-
2H-1-Benzopyran-2-one,4-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-
3-(.alpha.-Acetonylbenzyl)-4-hydroxycoumarin
3-(.alpha.-Phenyl-.beta.-acetylaethyl)-4-hydroxycumarin
3-(.alpha.-Phenyl-.beta.-acetylethyl)-4-hydroxycoumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(a-acetonylbenzyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin [German]
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
4-(4-hydroxy-2-oxo-2H-3-chromenyl)-4-phenyl-2-butanone
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine [Dutch]
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin [German]
4-hydroxy-3-(3-oxo-1-phenyl-butyl)chromen-2-one
4-hydroxy-3-(3-oxo-1-phenylbutyl)-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one #
4-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin, 97%
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin; 3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine [Italian]
4-oC>>u-3-(3-No u-1-+/-(1/2)>>u paragraph sign inverted exclamation mark>>u)-2H-1-+/-(1/2)(2) centssAa<<-2-I feminine
4OH-Coumarin deriv.
5-18-04-00162 (Beilstein Handbook Reference)
5543-56-6
56573-89-8
81-81-2
951658-59-6
A830639
AB00052125_02
AB0015503
AB00876255-06
AB1009569
AC-15978
AC1L1N37
AC1Q6AN3
AKOS005430103
AKOS026749956
AN-24048
Arab Rat Death
Arab rat deth
Athrombin
Athrombin-K
Athrombine K
Athrombine-K
BBL027615
BC209814
BDBM50343352
BEN360
BRD-A24514565-001-02-2
BRD-A24514565-236-01-6
BRN 1293536
Brumolin
BSPBio_002026
C01541
C19H16O4
CAS-81-81-2
Caswell No. 903
CBDivE_002127
CBDivE_013236
CBKinase1_000192
CBKinase1_012592
CCG-39672
CHEBI:87732
CHEMBL1464
CHEMBL7252
Choice (TN)
CO-Rax
Compound 42
Coumadin Tabs
Coumafen
Coumafene
Coumafene [French]
Coumaphen
Coumaphene
Coumarin, 3-(.alpha.-acetonylbenzyl)-4-hydroxy-
Coumarin, 3-(alpha-acetonylbenzyl)-4-hydroxy-
Coumarins
Coumefene
Cov-R-Tox
CPD000718754
CS-2926
CTK5A5361
D-Con
D08682
DB00682
delta-con
Dethmor
Dethnel
Dicusat E
DivK1c_000444
DL-3-(a-Acetonylbenzyl)-4-hydroxycoumarin
DL-3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
DL-3-(ALPHA-ACETONYLBENZYL)-4-HYDROXYCOUMARIN,TECH
DL-3-(alpha-ACETONYLBENZYL)-4-HYDROXYCOUMARINE, PURE
DSSTox_CID_3742
DSSTox_GSID_23742
DSSTox_RID_77177
DTXSID5023742
E+/-EoAeAAE
Eastern states duocide
EBD16262
EC 201-377-6
EINECS 201-377-6
EPA Pesticide Chemical Code 086002
Fasco fascrat powder
Frass-Ratron
FT-0631369
GTPL6853
HMS1921K07
HMS2092C20
HMS2233L10
HMS3372L19
HMS3648B15
HMS3714G21
HMS501G06
HSDB 1786
HY-B0687
I14-0958
IDI1_000444
KB-178378
KBio1_000444
KBio2_000674
KBio2_003242
KBio2_005810
KBio3_001526
KBioGR_000901
KBioSS_000674
Killgerm sewarin p
Kumader
Kumadu
Kumatox
Kypfarin
Latka 42
Latka 42 [Czech]
Liqua-tox
LS-55083
Maag Rattentod Cum
Mar-Frin
Martin's mar-frin
Maveran
MCULE-1618253893
MFCD00272376
MLS001304042
MolPort-001-787-822
MolPort-006-110-293
Mouse pak
NCGC00094810-01
NCGC00094810-02
NCGC00094810-03
NCGC00094810-04
NCGC00094810-05
NCGC00094810-06
NCGC00159398-03
NCGC00178855-01
NCGC00188986-01
NCGC00188986-02
NCGC00254457-01
NCGC00259731-01
NINDS_000444
NSC 59813
NSC-59813
NSC-757385
NSC59813
NSC757385
Panwarfin
Pharmakon1600-01500613
PJVWKTKQMONHTI-UHFFFAOYSA-N
Place-pax
Prothromadin
R-(+)-3-Acetonybenzyl)-4-hydroxycoumarin
R-(+)-4-Hydroxy-3-(3-oxo-1-phenybutyl)-2H-1-benzopyran-2-one
rac-Warfarin
Rat & mice bait
Rat and mice bait
Rat-a-way
Rat-alpha-way
Rat-B-gon
Rat-beta-gon
Rat-Gard
Rat-Kill
Rat-Mix
Rat-o-cide #2
Rat-o-cide No. 2
Rat-Ola
Rat-Trol
Ratorex
Ratox
Ratoxin
Ratron
Ratron G
Rats-no-more
Ratten-Koederrohr
Ratten-Koederrohr (German)
Rattenstreupulver Neu Schacht
Rattenstreupulver Neu Schacht (German)
Rattenstreupulver new schacht
Rattentraenke
Rattentraenke (German)
Rattunal
RAX
Rcr grey squirrel killer concentrate
RCRA waste no. P001
Rcra waste number P001
Ro-Deth
Rodafarin
Rodafarin C
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
s4545
Sakarat
SAM002564190
SBB058124
SBI-0051556.P002
SC-16139
SCHEMBL136434
SCHEMBL3689
Sewarin
SMP1_000316
SMR000718754
Sofarin
Solfarin
Sorexa plus
SPBio_000870
Spectrum_000194
SPECTRUM1500613
Spectrum2_000935
Spectrum3_000583
Spectrum4_000381
Spectrum5_001751
Spray-trol brand roden-trol
SR-01000195154
SR-01000195154-10
SR-01000195154-3
SR-01000195154-4
ST50308693
STK364490
Temus W
Tox-hid
Tox21_113185
Tox21_202182
Tox21_300531
Twin light rat away
Vampirinip II
Vampirinip iii
VC30411
W.A.R.F. 42
wafarin
Waran
Warf 42
WARF compound 42
Warfarat
warfarin
Warfarin (and salts of)
Warfarin (INN)
Warfarin [BSI:ISO]
Warfarin [INN:BAN]
Warfarin 1.0 mg/ml in Acetonitrile
Warfarin 100 microg/mL in Acetonitrile
Warfarin and salts, when present at concentration greater than 0.3%
Warfarin plus
Warfarin plus [discontinued]
Warfarin Q
Warfarin titrated to an INR of 2.5-3.0
Warfarin, analytical standard
Warfarin, British Pharmacopoeia (BP) Reference Standard
Warfarin, PESTANAL(R), analytical standard
Warfarin, United States Pharmacopeia (USP) Reference Standard
Warfarin4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-chromen-2-one
Warfarina
Warfarina [INN-Spanish]
Warfarine
Warfarine [INN-French]
Warfarine [ISO-French]
Warfarinum
Warfarinum [INN-Latin]
Warficide
WLN: T66 BOVJ DYR&1V1 EQ
Z1692482575
Zoocoumarin
Zoocoumarin [Netherlands and USSR]
Zoocoumarin [Russian]

US Patents and Regulatory Information for COUMADIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb COUMADIN warfarin sodium INJECTABLE;INJECTION 009218-024 Feb 7, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb COUMADIN warfarin sodium TABLET;ORAL 009218-025 Nov 18, 1996 AB RX Yes No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb COUMADIN warfarin sodium TABLET;ORAL 009218-022 Mar 1, 1990 AB RX Yes No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb COUMADIN warfarin sodium TABLET;ORAL 009218-005 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb COUMADIN warfarin sodium TABLET;ORAL 009218-023 Aug 24, 1993 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Moodys
McKesson
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.